What does Dr. Van Kesteren - Pediater do?

Dr. Van Kesteren - Pediater is a specialist medical practice in Brasschaat. Private Limited, started on 14 January 2022, 1 establishment.

What is the address of Dr. Van Kesteren - Pediater?

The registered office of Dr. Van Kesteren - Pediater is located at Gezondheidslei 37, 2930 Brasschaat.

Is Dr. Van Kesteren - Pediater still active?

Yes. According to the CBE (1 October 2026) Dr. Van Kesteren - Pediater is active, legal situation “Normale toestand”, started on 14 January 2022.

Is Dr. Van Kesteren - Pediater registered on Peppol?

Yes, Dr. Van Kesteren - Pediater is registered on the Peppol network with ID 0208:0780487536.

What is the enterprise number of Dr. Van Kesteren - Pediater?

The enterprise number of Dr. Van Kesteren - Pediater is BE0780487536.

When was Dr. Van Kesteren - Pediater founded?

Dr. Van Kesteren - Pediater was founded on 14 January 2022.

Who are the directors of Dr. Van Kesteren - Pediater?

According to the 2025 annual accounts, the directors of Dr. Van Kesteren - Pediater are: Lydia Van Kesteren.

Is Dr. Van Kesteren - Pediater a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 January 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Van Kesteren - Pediater make in 2025?

Dr. Van Kesteren - Pediater posted a profit after taxes of € 50,731 in financial year 2025.

What is the revenue of Dr. Van Kesteren - Pediater?

As a small company, Dr. Van Kesteren - Pediater is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 64,735.

Dr. Van Kesteren - Pediater (Private Limited)

Dossier Dr. Van Kesteren - Pediater, printed on 1 October 2026 from databakkes.be/en/0780487536/dr-van-kesteren-pediater. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 8 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Van Kesteren - Pediater from Brasschaat, company number BE0780487536, closed financial year 2025 with a result of € 50,731 after tax. For that financial year Dr. Van Kesteren - Pediater recorded a gross margin of € 64,735 and equity of € 63,894. Compared with financial year 2024, the result moved from € 29,358 to € 50,731. Profitable, and profit is growing. The buffer shrank hard: equity is 60 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.

What it is worth Shrank hard

€ 63,894

▼ 60% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 50,731

▲ 73% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3,188

▼ 82% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 148,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,002

▼ 38% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,732

▲ € 2,675 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,297

▲ 176% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 88,411 Gross margin 2022: € 88,411 First fiscal year in the series	€ 74,215 Gross margin 2023: € 74,215 ▼ 16% vs 2022 (€ 88,411) Unfavourable step	€ 37,989 Gross margin 2024: € 37,989 ▼ 49% vs 2023 (€ 74,215) Unfavourable step	€ 64,735 Gross margin 2025: € 64,735 ▲ 70% vs 2024 (€ 37,989) Favourable step	▲ 70%
Profit after taxes	€ 70,019 Profit after taxes 2022: € 70,019 First fiscal year in the series	€ 57,619 Profit after taxes 2023: € 57,619 ▼ 18% vs 2022 (€ 70,019) Unfavourable step	€ 29,358 Profit after taxes 2024: € 29,358 ▼ 49% vs 2023 (€ 57,619) Unfavourable step	€ 50,731 Profit after taxes 2025: € 50,731 ▲ 73% vs 2024 (€ 29,358) Favourable step	▲ 73%
Equity	€ 75,019 Equity 2022: € 75,019 First fiscal year in the series	€ 132,638 Equity 2023: € 132,638 ▲ 77% vs 2022 (€ 75,019) Favourable step	€ 161,163 Equity 2024: € 161,163 ▲ 22% vs 2023 (€ 132,638) Favourable step	€ 63,894 Equity 2025: € 63,894 ▼ 60% vs 2024 (€ 161,163) Unfavourable step	▼ 60%
Total debts	€ 2,270 Total debts 2022: € 2,270 First fiscal year in the series	€ 5,895 Total debts 2023: € 5,895 ▲ 160% vs 2022 (€ 2,270) Unfavourable step	€ 4,261 Total debts 2024: € 4,261 ▼ 28% vs 2023 (€ 5,895) Favourable step	€ 37,873 Total debts 2025: € 37,873 ▲ € 33,612 vs 2024 (€ 4,261) Unfavourable step	▲ € 33,612
Cash	€ 25,452 Cash 2022: € 25,452 First fiscal year in the series	€ 16,325 Cash 2023: € 16,325 ▼ 36% vs 2022 (€ 25,452) Unfavourable step	€ 17,597 Cash 2024: € 17,597 ▲ 8% vs 2023 (€ 16,325) Favourable step	€ 3,188 Cash 2025: € 3,188 ▼ 82% vs 2024 (€ 17,597) Unfavourable step	▼ 82%
Retained profit	€ 70,019 Retained profit 2022: € 70,019 First fiscal year in the series	€ 127,638 Retained profit 2023: € 127,638 ▲ 82% vs 2022 (€ 70,019) Favourable step	€ 156,163 Retained profit 2024: € 156,163 ▲ 22% vs 2023 (€ 127,638) Favourable step	€ 58,894 Retained profit 2025: € 58,894 ▼ 62% vs 2024 (€ 156,163) Unfavourable step	▼ 62%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 833 Dividend 2024: € 833 Unchanged (€ 0) Unchanged	€ 148,000 Dividend 2025: € 148,000 ▲ € 147,167 vs 2024 (€ 833) Unchanged	▲ € 147,167
Balance sheet total	€ 77,289 Balance sheet total 2022: € 77,289 First fiscal year in the series	€ 138,533 Balance sheet total 2023: € 138,533 ▲ 79% vs 2022 (€ 77,289) Unchanged	€ 165,423 Balance sheet total 2024: € 165,423 ▲ 19% vs 2023 (€ 138,533) Unchanged	€ 101,767 Balance sheet total 2025: € 101,767 ▼ 38% vs 2024 (€ 165,423) Unchanged	▼ 38%

Key figures of Dr. Van Kesteren - Pediater, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Van Kesteren - Pediater?

What happened at Dr. Van Kesteren - Pediater in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 18, 2026 New annual accounts for financial year 2025: profit of € 50,731 (▲ 73% vs 2024). Source: NBB ↗
Jan 14, 2022 New establishment in Brasschaat. KBO
Jan 14, 2022 Start of the company according to the CBE. KBO
2022 Lydia Van Kesteren became a director. NBB

In short

From € 70,019 profit in 2022 to € 50,731 profit in 2025.

Paid € 54,585 in corporate taxes since 2022.

Best year ever: 2022, with € 70,019 profit.

Paid out € 148,833 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Van Kesteren - Pediater? We notify you, reason included.

Follow Dr. Van Kesteren - Pediater

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Lydia Van Kesteren

Dr. Van Kesteren - Pediater

Behind Dr. Van Kesteren - Pediater is Lydia Van Kesteren.

See the full network in the app

Directors

According to the 2025 annual accounts

Lydia Van Kesteren

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Gezondheidslei 37

2930 Brasschaat

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0780.487.536
VAT number: BE 0780.487.536
Registered office: Gezondheidslei 37, 2930 Brasschaat
Names & denominations: Dr. Van Kesteren - Pediater
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 January 2022
Peppol: Active · Active since 24 Nov 2023
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗